MARSHALL WACE, LLP: ABBV position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on ABBV, newest first. How the timeline and the estimate are built.
MARSHALL WACE, LLP held 2,990,512 ABBV shares at 2026-06-30 per its 13F-HR filed 2026-08-13.
the latest 13F is the newest step
- period ended2026-06-3013F 2,990,512 sharesChange vs previous 13F +2,989,451 shares
0.64% of the 13F portfolio, value $752,532,440.
13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 1,061 sharesChange vs previous 13F -648,939 shares
<0.01% of the 13F portfolio, value $230,757.
13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 650,000 sharesChange vs previous 13F -627,167 shares
0.14% of the 13F portfolio, value $148,518,500.
13F-HR 0001318757-26-000003 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,277,167 sharesChange vs previous 13F -102,168 shares
0.32% of the 13F portfolio, value $295,715,246.
13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,379,335 sharesChange vs previous 13F +1,137,548 shares
0.3% of the 13F portfolio, value $256,032,163.
13F-HR 0001318757-25-000034 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 241,787 sharesChange vs previous 13F -1,335,108 shares
0.07% of the 13F portfolio, value $50,659,212.
13F-HR 0001318757-25-000023 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 1,576,895 sharesChange vs previous 13F +247,726 shares
0.35% of the 13F portfolio, value $280,214,242.
13F-HR 0002048047-25-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 1,329,169 sharesChange vs previous 13F not available
0.34% of the 13F portfolio, value $262,484,292.
13F-HR 0001318757-24-000018 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).